Sato, T., A. Neschadim, M. Konrad, D. H. Fowler, A. Lavie and J. A. Medin: Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. In: Molecular Therapy 15, 5, 962-970 (2007).
url: http://www.nature.com/mt/journal/v15/n5/full/6300122a.html
Sato, T., A. Neschadim, V. Rasaiah, M. Konrad, A. Lavie and J. A. Medin: Development of a novel lentivirus-based suicide gene therapy approach using modified human thymidylate monophosphate kinase. In: Journal of Gene Medicine 8, 3 (2006) 399-399.
url: http://www3.interscience.wiley.com/cgi-bin/fulltext/112467942/HTMLSTART
Sato, T., A. Neschadim, V. Rasaiah, M. Konrad, D. H. Fowler, A. Lavie and J. A. Medin: A novel suicide gene therapy approach for reduction of GvHD using lentiviral delivery of a modified human thymidylate monophosphate kinase. In: Blood 106, 11 (2005) 397B-397B.
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.